Coherus Biosciences (CHRS) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

| --- | --- | |-------|-------| | | | | | | | | | Copyright ©2021 All Rights Reserved. Forward Looking Statements Except for the historical information contained herein, the matters set forth in this primer are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, Coherus' potential market opportunity for its biosimilar product candidates, if approved; plans to file the BLA for Bioeq's biosimilar ...